Micelle-Forming Block Copolymers Tailored for Inhibition of P-gp-Mediated Multidrug Resistance: Structure to Activity Relationship.
P-glycoprotein
block copolymers
micelles
multidrug resistance
polymer therapeutics
solid tumors
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
05 Nov 2019
05 Nov 2019
Historique:
received:
01
10
2019
revised:
21
10
2019
accepted:
04
11
2019
entrez:
8
11
2019
pubmed:
7
11
2019
medline:
7
11
2019
Statut:
epublish
Résumé
Multidrug resistance (MDR) is often caused by the overexpression of efflux pumps, such as ABC transporters, in particular, P-glycoprotein (P-gp). Here, we investigate the di- and tri- block amphiphilic polymer systems based on polypropylene glycol (PPO) and copolymers of (
Identifiants
pubmed: 31694350
pii: pharmaceutics11110579
doi: 10.3390/pharmaceutics11110579
pmc: PMC6920990
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ministerstvo Zdravotnictví Ceské Republiky
ID : 16-28600A
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Control Release. 2000 Feb 14;64(1-3):143-53
pubmed: 10640653
J Control Release. 2000 Mar 1;65(1-2):271-84
pubmed: 10699287
Biomacromolecules. 2019 Apr 8;20(4):1798-1815
pubmed: 30785284
Biomacromolecules. 2018 Oct 8;19(10):4003-4013
pubmed: 30180562
Adv Drug Deliv Rev. 2002 Sep 13;54(5):759-79
pubmed: 12204601
Biomacromolecules. 2014 Aug 11;15(8):3030-43
pubmed: 24978588
Adv Drug Deliv Rev. 2011 Mar 18;63(3):136-51
pubmed: 20441782
J Control Release. 2016 Jul 10;233:136-46
pubmed: 27189135
Nat Rev Drug Discov. 2006 Mar;5(3):219-34
pubmed: 16518375
Small. 2008 Nov;4(11):2043-50
pubmed: 18949788
Chem Rev. 2002 Feb;102(2):285-303
pubmed: 11841244
Biomacromolecules. 2006 Jan;7(1):122-30
pubmed: 16398506
Chem Rev. 2016 May 11;116(9):5338-431
pubmed: 27109701
Anal Bioanal Chem. 2017 May;409(12):3135-3143
pubmed: 28235995
Nanoscale. 2018 Mar 29;10(13):6194-6204
pubmed: 29560983
Eur J Pharm Sci. 2010 Nov 20;41(3-4):473-82
pubmed: 20696244
Adv Drug Deliv Rev. 2013 Nov;65(13-14):1866-79
pubmed: 24120656
Cancer Sci. 2016 Jul;107(7):867-74
pubmed: 27116635
J Control Release. 2005 Dec 10;110(1):103-18
pubmed: 16274831
Mol Pharm. 2014 Aug 4;11(8):2566-78
pubmed: 24950236
Naunyn Schmiedebergs Arch Pharmacol. 2009 Jan;379(1):11-26
pubmed: 18758752
Adv Enzyme Regul. 2001;41:189-207
pubmed: 11384745
J Control Release. 2014 Sep 28;190:465-76
pubmed: 24993430
Drug Discov Today. 2012 Apr;17(7-8):343-51
pubmed: 22119877
J Control Release. 2001 Jul 6;74(1-3):47-61
pubmed: 11489482
J Drug Target. 2004;12(8):477-89
pubmed: 15621674
Biomacromolecules. 2018 Aug 13;19(8):3515-3524
pubmed: 30011367
Drug Metab Dispos. 2014 Apr;42(4):623-31
pubmed: 24492893
J Chem Inf Model. 2011 Jun 27;51(6):1447-56
pubmed: 21604677
J Control Release. 2017 Jan 10;245:41-51
pubmed: 27871991
Int J Pharm. 2017 Oct 30;532(1):249-268
pubmed: 28882486
Biomaterials. 2017 Jan;115:65-80
pubmed: 27886555
J Control Release. 2008 Sep 10;130(2):98-106
pubmed: 18534704
Adv Drug Deliv Rev. 2001 Mar 23;47(1):113-31
pubmed: 11251249